ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000233203.2	AKT inhibitor VIII	Chronic Lymphocytic Leukemia	0.025152486	Resistant
ENSG00000233203.2	AKT inhibitor VIII	Skin cutaneous melanoma	0.041751762	Resistant